ADIPOQ and cardiovascular disorder: In this study in a British South-Asian population with a high incidence of type 2 diabetes, cardiovascular disease, central obesity and metabolic syndrome, we have demonstrated that serum adiponectin levels are inversely correlated across the glycaemic spectrum with patients of type 2 diabetes having the lowest levels.